Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical Biochemistry

• Publication date

  2012-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.clinbiochem.2012.06.012PMID 22728012
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma.

  2013cited by this paper
• Molecular cloning of novel alternatively spliced variants of BCL2L12, a new member of the BCL2 gene family, and their expression analysis in cancer cells.

  2012cited by this paper
• The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.

  2011cited by this paper
• BCL2L12 is a Novel Biomarker for the Prediction of Short-Term Relapse in Nasopharyngeal Carcinoma

  2011cited by this paper
• Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma

  2010cited by this paper
• Quantitative analysis of BCL2 mRNA expression in nasopharyngeal carcinoma: an unfavorable and independent prognostic factor

  2010cited by this paper
• Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor.

  2010cited by this paper
• Molecular analysis and prognostic impact of the novel apoptotic gene BCL2L12 in gastric cancer.

  2010cited by this paper
• A natural antisense transcript, BOKAS, regulates the pro-apoptotic activity of human Bok.

  2009cited by this paper
• WT1 mRNA level in peripheral blood is a sensitive biomarker for monitoring minimal residual disease in acute myeloid leukemia.

  2009cited by this paper
• A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects.

  2009cited by this paper
• HSP70 protects BCL2L12 and BCL2L12A from N‐terminal ubiquitination‐mediated proteasomal degradation

  2009cited by this paper
• Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma

  2008cited by this paper
• Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer

  2008cited by this paper
• What drives intense apoptosis resistance and propensity for necrosis in glioblastoma? A role for Bcl2L12 as a multifunctional cell death regulator

  2008cited by this paper
• Increased C-kit intensity is a poor prognostic factor for progression-free and overall survival in patients with newly diagnosed AML.

  2008cited by this paper
• Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

  2007cited by this paper
• Transcriptional Interferences in cis Natural Antisense Transcripts of Humans and Mice

  2007cited by this paper
• Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma.

  2007cited by this paper
• Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer.

  2007cited by this paper
• BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications.

  2006cited by this paper
• Acute myeloid leukaemia.

  2006cited by this paper
• High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics.

  2006cited by this paper
• Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells

  2006cited by this paper
• Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction.

  2006cited by this paper
• Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222.

  2005cited by this paper
• Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study.

  2005cited by this paper
• Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer

  2004cited by this paper
• Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML).

  2003cited by this paper
• Expression of BCL2L12, a new member of apoptosis-related genes, in breast tumors

  2003cited by this paper
• Cisplatin‐Induced Apoptosis in HL‐60 Human Promyelocytic Leukemia Cells

  2003cited by this paper
• High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML)

  2002cited by this paper
• In Vitro Selection and Characterization of Bcl-XL-binding Proteins from a Mix of Tissue-specific mRNA Display Libraries*

  2001cited by this paper
• Molecular cloning, physical mapping, and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2 domain of the Bcl-2 family.

  2001cited by this paper
• Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia

  2001cited by this paper
• Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.

  2001cited by this paper
• BAX and PKCα Modulate the Prognostic Impact of BCL2 Expression in Acute Myelogenous Leukemia

  2000cited by this paper
• BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia.

  2000cited by this paper
• The prognostic impact of BCL2 protein expression in acute myelogenous leukemia varies with cytogenetics.

  1999cited by this paper
• Acute myeloid leukemia.

  1999cited by this paper
• Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance.

  1998cited by this paper
• A Potent Cell Death Activity Associated with Transient High Level Expression of BCL-2*

  1998cited by this paper
• The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

  1998cited by this paper
• Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemia.

  1998cited by this paper
• Caspase 2 and Caspase 3 Protein Levels as Predictors of Survival in Acute Myelogenous Leukemia

  1998cited by this paper
• Caspases: the executioners of apoptosis.

  1997cited by this paper
• High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate

  1997cited by this paper
• Internal tandem duplication of the flt3 gene found in acute myeloid leukemia.

  1996cited by this paper
• ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements.

  1994cited by this paper
• High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy.

  1993cited by this paper

• Exploring the Potential of siRNA Delivery in Acute Myeloid Leukemia for Therapeutic Silencing

  2023cites this paper
• Expression of BCL2L12and LIPOCALIN 2 in Adult Patient with Acute Myeloid Leukemia and Correlation with Clinical Response

  2021cites this paper
• Complex transcriptional regulation of the BCL2L12 gene: novel, active promoter in K562 cells.

  2020cites this paper
• BCL2L12: a multiply spliced gene with independent prognostic significance in breast cancer

  2018cites this paper
• Identification of novel alternative splice variants of the BCL2L12 gene in human cancer cells using next-generation sequencing methodology.

  2016cites this paper
• Expression of BCL2L12 in acute leukemia patients: Potential association with clinical and prognostic factors

  2016cites this paper
• The novel function of CD82 and its impact on BCL2L12 via AKT/STAT5 signal pathway in acute myelogenous leukemia cells

  2015cites this paper
• Mutation-profile-based methods for understanding selection forces in cancer somatic mutations: a comparative analysis

  2015cites this paper
• A New Mutation-Profile-Based Method for Understanding the Evolution of Cancer Somatic Mutations

  2015cites this paper
• Impact of promoter polymorphisms in key regulators of the intrinsic apoptosis pathway on the outcome of childhood acute lymphoblastic leukemia

  2014cites this paper
• BCL2L12: a promising molecular prognostic biomarker in breast cancer.

  2014cites this paper
• Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors.

  2014cites this paper
• Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma.

  2013cites this paper